Section 20-576-30 - Disclosing the price of legend drugs(a) As used in section 20-611 of the General Statutes, and in this section, "prospective purchaser" means a person for whom a prescription has been issued in compliance with section 20-614 of the General Statutes, or the patient's authorized agent or, in the case of a minor or incompetent person, the patient's parent or guardian, and who is making an inquiry either in person or by telephone to a pharmacist for the price of said prescription.(b) For the purpose of complying with section 20-611 of the General Statutes, and in order to have sufficient information to disclose a prescription price, a pharmacist may ask a prospective purchaser making an inquiry in person or by telephone, or any other person making such an inquiry on behalf of the prospective purchaser for the following: (1) The name of the medication (brand or generic);(2) Dose or strength, if applicable; and(c) In the event that the prospective purchaser or other person making such an inquiry on his or her behalf cannot provide any of the information listed in subsection (b) of this section, and such information is necessary for the requested price to be determined, then the pharmacist may contact the prescribing practitioner in order to obtain the necessary information prior to disclosing the prescription price.(d) Where substitution of a generic drug product is authorized pursuant to section 20-619 of the General Statutes, the pharmacist shall disclose the price of the substituted drug product. In so doing, however, the pharmacist shall also disclose the brand name or the generic name of said substituted drug product. The pharmacist shall also disclose the name of the drug manufacturer of the substituted drug product and otherwise comply with the provisions of section 20-619 of the General Statutes.Conn. Agencies Regs. § 20-576-30
Adopted effective January 11, 1999